Enter assignee name

Forward Citations = 69

Loading Chart...

12 inventors (with patents filed for the assignee):

Jay Copeland Strum (6 out of 56 patents)

Francis Xavier Tavares (5 out of 47 patents)

Patrick Joseph Roberts (3 out of 25 patents)

4. John Emerson Bisi (3 out of 23 patents)

5. Hannah S White (2 out of 13 patents)

6. Lei Zhu (1 out of 11 patents)

7. Jessica A Sorrentino (1 out of 8 patents)

8. Petinka I Vlahova (1 out of 27 patents)

9. Patricia Andres (1 out of 41 patents)

10. Alexander Smith (1 out of 17 patents)

11. Xufeng Sun (1 out of 3 patents)

12. David Kendall Jung (1 out of 15 patents)

8 patents: Sort by Forward Citations

1. 11261193 - Morphic forms of G1T38 and methods of manufacture thereof (2022-03-01),

2. 10927120 - CDK inhibitors (2021-02-23),

3. 10829490 - Substituted dihydropyrazino[1 ',2′:1,5]pyrrolo[2,3-d]pyrimidine-based antiproliferative agents (2020-11-10),

4. 10660896 - Transient protection of normal cells during chemotherapy (2020-05-26),

5. 10464940 - Lactam kinase inhibitors (2019-11-05),

6. 10231969 - Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors (2019-03-19),

7. 9957276 - CDK inhibitors (2018-05-01),

8. 9527857 - HSPC-sparing treatments for RB-positive abnormal cellular proliferation (2016-12-27),

Gi Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for gastrointestinal disorders. Our mission is to improve the quality of life for patients suffering from conditions such as irritable bowel syndrome and inflammatory bowel disease. With a dedicated team of researchers and scientists, we are committed to advancing treatment options for these chronic diseases.

This text is generated by artificial intelligence and may not be accurate.